Wuhan Institute
Establishment time : 1958
website : http://english.whiov.cas.cn/
Main Product : Research and development of vaccines, diagnostic kits, and antiviral drugs
Company Profile
The Wuhan Institute of Virology is a prominent research institute in China, specializing in the study of viruses and infectious diseases. Established in 1958, the institute has made significant contributions to the development of vaccines, diagnostic kits, and antiviral drugs. With a team of over 600 employees, the institute is at the forefront of research in the field of virology and is recognized globally for its expertise in studying emerging infectious diseases.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Changchun Institute
Establishment time : 1958
website : www.cjlu.edu.cn
Main Product : Research and development in various fields such as engineering, materials science, and environmental science
Company Profile
Changchun Institute is a prestigious research institute in China, known for its cutting-edge research and development in various fields. With a large team of experts and state-of-the-art facilities, the institute has made significant contributions to scientific advancements and technological innovations.
Rabipur
Establishment time : 1984
website : www.rabipur.com
Main Product : Rabies vaccine
Company Profile
Rabipur is a leading pharmaceutical company specializing in the production of rabies vaccines. Established in 1984, the company has grown to become a major player in the global market, providing high-quality vaccines to prevent rabies in both humans and animals. With a large presence and distribution network, Rabipur continues to innovate and improve its products to meet the growing demand for rabies prevention worldwide.
Yisheng
Establishment time : 2005
website : www.yisheng.com
Main Product : automotive parts, engine components
Company Profile
Yisheng is a leading manufacturer of high-quality automotive parts and engine components. With a strong presence in the global market, the company is known for its reliability and innovation in the industry. Established in 2005, Yisheng continues to grow and expand its product offerings to meet the needs of customers worldwide.